Events
Start of main content
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023 ,y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
The impossible takes longer
Katalin Karikó*, Premio Nobel de Medicina 2023, y George Smoot, Premio Nobel de Física 2006, compartirán con nosotros su enfoque de la investigación científica.
*Participa online
Madrid
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Asistencia gratuita hasta completar aforo. Necesaria inscripción online previa. Interpretación simultánea.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
DATE: 27 June 2024
TIME: 18:30 - 20:30 (CEST)
VENUE: Fundación Ramón Areces - salón de actos. Calle Vitruvio, 5. 28006. Madrid.
Free admission until full capacity is reached. Necessary previous online registration. Limited capacity.
Nobel Prize Conversations in partnership with
Nobel International Partners
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Event information
Just sometimes, everyone else is wrong. They insist that your idea won’t work, your finding is wrong, your scheme is mad. For many Nobel Prize laureates, that was the starting point. But, ignoring other peoples’ preconceptions about what is possible, they went ahead anyway. And, eventually, the results made history. Treading a solo path can, however, be a lonely business, and you need confidence, strength and resilience to persevere.
In this conversation we will bring together two Nobel Prize laureates to explore the dangers of always trusting received wisdom and the strategies that can help you survive and flourish if you decide to go your own way.
The evening will feature George Smoot (2006 Nobel Prize laureate in physics), who detected the seeds of the first galaxies in the echoes of the big bang, and, joining us online, Katalin Karikó, (2023 Nobel Prize laureate in physiology or medicine), who pioneered the development of mRNA vaccines, so essential in combating the Covid-19 pandemic.
Moderating the conversation will be Adam Smith, host of the Nobel Prize Conversations podcast from nobelprize.org, which this season investigates the lives and works of the 2023 Nobel Prize laureates.
Speakers
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot recibió el Premio Nobel por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Ha participado en las misiones Planck y Euclid. Galardonado con el Premio Nobel de Física 2006 por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Smoot obtuvo una doble licenciatura (1966) en Matemáticas y Física y un doctorado (1970) en Física por el Instituto Tecnológico de Massachusetts (MIT). Smoot trabaja en la Universidad de California Berkeley y en el Laboratorio Nacional Lawrence Berkeley desde 1970.
En abril de 1992, Smoot anunció que el equipo COBE DMR que dirigía, había detectado las tan buscadas variaciones en el universo primitivo que son las semillas que -bajo la influencia de la gravedad- crecen hasta convertirse en las galaxias, cúmulos de galaxias y cúmulos de cúmulos que se observan en el universo actual. El satélite COBE (Explorador del Fondo Cósmico) de la NASA cartografió la intensidad de la radiación del Big Bang primitivo y descubrió variaciones de amplitud muy pequeñas. Estas variaciones también son reliquias de la creación.
Autor de más de 600 artículos científicos y coautor (con Keay Davidson) del libro de divulgación científica «Arrugas en el tiempo» (Harper, 1994), que explica la cosmología y el descubrimiento del COBE. El ensayo de Smoot «My Einstein Suspenders» aparece en 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy» (Ed. John Brockman, Pantheon, 2006).
Smoot ha seguido investigando en cosmología y ha participado en las misiones Planck y Euclid. La misión Planck es la tercera generación de misiones para explotar las fluctuaciones del CMB descubiertas por COBE DMR. Euclid es una misión para comprender la energía oscura causante de la aceleración de la expansión actual del universo.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot recibió el Premio Nobel por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Ha participado en las misiones Planck y Euclid. Galardonado con el Premio Nobel de Física 2006 por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Smoot obtuvo una doble licenciatura (1966) en Matemáticas y Física y un doctorado (1970) en Física por el Instituto Tecnológico de Massachusetts (MIT). Smoot trabaja en la Universidad de California Berkeley y en el Laboratorio Nacional Lawrence Berkeley desde 1970.
En abril de 1992, Smoot anunció que el equipo COBE DMR que dirigía, había detectado las tan buscadas variaciones en el universo primitivo que son las semillas que -bajo la influencia de la gravedad- crecen hasta convertirse en las galaxias, cúmulos de galaxias y cúmulos de cúmulos que se observan en el universo actual. El satélite COBE (Explorador del Fondo Cósmico) de la NASA cartografió la intensidad de la radiación del Big Bang primitivo y descubrió variaciones de amplitud muy pequeñas. Estas variaciones también son reliquias de la creación.
Autor de más de 600 artículos científicos y coautor (con Keay Davidson) del libro de divulgación científica «Arrugas en el tiempo» (Harper, 1994), que explica la cosmología y el descubrimiento del COBE. El ensayo de Smoot «My Einstein Suspenders» aparece en 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy» (Ed. John Brockman, Pantheon, 2006).
Smoot ha seguido investigando en cosmología y ha participado en las misiones Planck y Euclid. La misión Planck es la tercera generación de misiones para explotar las fluctuaciones del CMB descubiertas por COBE DMR. Euclid es una misión para comprender la energía oscura causante de la aceleración de la expansión actual del universo.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot recibió el Premio Nobel por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Ha participado en las misiones Planck y Euclid. Galardonado con el Premio Nobel de Física 2006 por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Smoot obtuvo una doble licenciatura (1966) en Matemáticas y Física y un doctorado (1970) en Física por el Instituto Tecnológico de Massachusetts (MIT). Smoot trabaja en la Universidad de California Berkeley y en el Laboratorio Nacional Lawrence Berkeley desde 1970.
En abril de 1992, Smoot anunció que el equipo COBE DMR que dirigía, había detectado las tan buscadas variaciones en el universo primitivo que son las semillas que -bajo la influencia de la gravedad- crecen hasta convertirse en las galaxias, cúmulos de galaxias y cúmulos de cúmulos que se observan en el universo actual. El satélite COBE (Explorador del Fondo Cósmico) de la NASA cartografió la intensidad de la radiación del Big Bang primitivo y descubrió variaciones de amplitud muy pequeñas. Estas variaciones también son reliquias de la creación.
Autor de más de 600 artículos científicos y coautor (con Keay Davidson) del libro de divulgación científica «Arrugas en el tiempo» (Harper, 1994), que explica la cosmología y el descubrimiento del COBE. El ensayo de Smoot «My Einstein Suspenders» aparece en 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy» (Ed. John Brockman, Pantheon, 2006).
Smoot ha seguido investigando en cosmología y ha participado en las misiones Planck y Euclid. La misión Planck es la tercera generación de misiones para explotar las fluctuaciones del CMB descubiertas por COBE DMR. Euclid es una misión para comprender la energía oscura causante de la aceleración de la expansión actual del universo.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot recibió el Premio Nobel por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Ha participado en las misiones Planck y Euclid. Galardonado con el Premio Nobel de Física 2006 por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Smoot obtuvo una doble licenciatura (1966) en Matemáticas y Física y un doctorado (1970) en Física por el Instituto Tecnológico de Massachusetts (MIT). Smoot trabaja en la Universidad de California Berkeley y en el Laboratorio Nacional Lawrence Berkeley desde 1970.
En abril de 1992, Smoot anunció que el equipo COBE DMR que dirigía, había detectado las tan buscadas variaciones en el universo primitivo que son las semillas que -bajo la influencia de la gravedad- crecen hasta convertirse en las galaxias, cúmulos de galaxias y cúmulos de cúmulos que se observan en el universo actual. El satélite COBE (Explorador del Fondo Cósmico) de la NASA cartografió la intensidad de la radiación del Big Bang primitivo y descubrió variaciones de amplitud muy pequeñas. Estas variaciones también son reliquias de la creación.
Autor de más de 600 artículos científicos y coautor (con Keay Davidson) del libro de divulgación científica «Arrugas en el tiempo» (Harper, 1994), que explica la cosmología y el descubrimiento del COBE. El ensayo de Smoot «My Einstein Suspenders» aparece en 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy» (Ed. John Brockman, Pantheon, 2006).
Smoot ha seguido investigando en cosmología y ha participado en las misiones Planck y Euclid. La misión Planck es la tercera generación de misiones para explotar las fluctuaciones del CMB descubiertas por COBE DMR. Euclid es una misión para comprender la energía oscura causante de la aceleración de la expansión actual del universo.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot recibió el Premio Nobel por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Ha participado en las misiones Planck y Euclid. Galardonado con el Premio Nobel de Física 2006 por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Smoot obtuvo una doble licenciatura (1966) en Matemáticas y Física y un doctorado (1970) en Física por el Instituto Tecnológico de Massachusetts (MIT). Smoot trabaja en la Universidad de California Berkeley y en el Laboratorio Nacional Lawrence Berkeley desde 1970.
En abril de 1992, Smoot anunció que el equipo COBE DMR que dirigía, había detectado las tan buscadas variaciones en el universo primitivo que son las semillas que -bajo la influencia de la gravedad- crecen hasta convertirse en las galaxias, cúmulos de galaxias y cúmulos de cúmulos que se observan en el universo actual. El satélite COBE (Explorador del Fondo Cósmico) de la NASA cartografió la intensidad de la radiación del Big Bang primitivo y descubrió variaciones de amplitud muy pequeñas. Estas variaciones también son reliquias de la creación.
Autor de más de 600 artículos científicos y coautor (con Keay Davidson) del libro de divulgación científica «Arrugas en el tiempo» (Harper, 1994), que explica la cosmología y el descubrimiento del COBE. El ensayo de Smoot «My Einstein Suspenders» aparece en 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy» (Ed. John Brockman, Pantheon, 2006).
Smoot ha seguido investigando en cosmología y ha participado en las misiones Planck y Euclid. La misión Planck es la tercera generación de misiones para explotar las fluctuaciones del CMB descubiertas por COBE DMR. Euclid es una misión para comprender la energía oscura causante de la aceleración de la expansión actual del universo.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot recibió el Premio Nobel por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Ha participado en las misiones Planck y Euclid. Galardonado con el Premio Nobel de Física 2006 por «el descubrimiento de la forma de cuerpo negro y la anisotropía de la radiación cósmica de fondo de microondas». Smoot obtuvo una doble licenciatura (1966) en Matemáticas y Física y un doctorado (1970) en Física por el Instituto Tecnológico de Massachusetts (MIT). Smoot trabaja en la Universidad de California Berkeley y en el Laboratorio Nacional Lawrence Berkeley desde 1970.
En abril de 1992, Smoot anunció que el equipo COBE DMR que dirigía, había detectado las tan buscadas variaciones en el universo primitivo que son las semillas que -bajo la influencia de la gravedad- crecen hasta convertirse en las galaxias, cúmulos de galaxias y cúmulos de cúmulos que se observan en el universo actual. El satélite COBE (Explorador del Fondo Cósmico) de la NASA cartografió la intensidad de la radiación del Big Bang primitivo y descubrió variaciones de amplitud muy pequeñas. Estas variaciones también son reliquias de la creación.
Autor de más de 600 artículos científicos y coautor (con Keay Davidson) del libro de divulgación científica «Arrugas en el tiempo» (Harper, 1994), que explica la cosmología y el descubrimiento del COBE. El ensayo de Smoot «My Einstein Suspenders» aparece en 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy» (Ed. John Brockman, Pantheon, 2006).
Smoot ha seguido investigando en cosmología y ha participado en las misiones Planck y Euclid. La misión Planck es la tercera generación de misiones para explotar las fluctuaciones del CMB descubiertas por COBE DMR. Euclid es una misión para comprender la energía oscura causante de la aceleración de la expansión actual del universo.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó es profesora en la Universidad de Szeged y profesora adjunta de neurocirugía en la Perelman School of Medicine de la Universidad de Pensilvania, donde ha trabajado durante 24 años. Fue vicepresidenta sénior de BioNTech SE, Mainz (Alemania), donde trabajó entre 2013 y 2022. Se doctoró en bioquímica por la Universidad de Szeged (Hungría) en 1982.
Durante cuatro décadas, su investigación se ha centrado en los mecanismos mediados por ARN con el objetivo final de desarrollar ARN mensajero (ARNm) transcrito in vitro para la terapia con proteínas. Investigó la activación inmunitaria mediada por ARN y co-descubrió que las modificaciones de nucleósidos suprimen la inmunogenicidad del ARN, lo que amplió el potencial terapéutico del ARNm. Sus patentes, co-inventadas con Drew Weissman, sobre uridinas modificadas con nucleósidos en el ARNm, se han utilizado para crear las vacunas para COVID-19 basadas en ARNm, desarrolladas por Bi-oNTech/Pfizer y Moderna y aprobadas por la FDA para luchar contra la pandemia.
Por sus logros ha recibido numerosos galardones de prestigio, como el Premio Japón, el Premio Horwitz, el Premio Franklin, el Premio Princesa Asturias, el Premio BBVA, el Premio Jiménez Díaz, el Premio Breakthrough, el Premio Lasker-DeBakey de Investigación Médica Clínica y el Premio Nobel de Fisiología o Medicina 2023.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
Speakers
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
George Smoot
George Smoot was awarded the Nobel Prize for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation. He has been involved in the Planck and Euclid missions.
George Smoot was co-awarded the 2006 Nobel Prize in Physics for "discovery of the blackbody form and anisotropy of the cosmic microwave background radiation." Smoot received dual bachelor's degrees (1966) in mathematics and physics and a PhD (1970) in physics from the Massachusetts Institute of Technology (MIT). Smoot has been at the University of California Berkeley and the Lawrence Berkeley National Laboratory since 1970.
In April 1992, Smoot announced that the COBE DMR team he led had detected the long-sought variations in the early universe which are the seeds that - under the influence of gravity - grow to be the galaxies, clusters of galaxies, and clusters of clusters that are observed in the universe today. NASA's COBE (Cosmic Background Explorer) satellite mapped the intensity of the radiation from the early Big Bang and found very small amplitude variations. These variations are also relics of creation.
Smoot has authored more than 600 science papers and is also co-author (with Keay Davidson) of the popular science book 'Wrinkles in Time' (Harper, 1994), which elucidates cosmology and the COBE discovery. Smoot's essay "My Einstein Suspenders" appears in 'My Einstein: Essays by Twenty-four of the World's Leading Thinkers on the Man', His Work, and His Legacy' (Ed. John Brockman, Pantheon, 2006).
Smoot has continued his research in cosmology and he has been involved in the Planck and Euclid missions. The Planck mission is the third-generation mission to exploit the CMB fluctuations discovered by COBE DMR. Euclid is a mission to understand the dark energy causing the current expansion of the universe to accelerate.
Raimundo Pérez-Hernández y Torra
Raimundo Pérez-Hernández y Torra, es director de la Fundación Ramón Areces desde 2008. Licenciado en Derecho por la Universidad Complutense de Madrid ingresó en la Carrera Diplomática en 1976. Hasta su incorporación a la Fundación Ramón Areces desarrolló su carrera profesional en la Administración Pública, donde ha ocupado los cargos de consejero en la Delegación Permanente de España ante la Oficina de las Naciones Unidas; consejero económico y comercial en la Embajada de España en la República Francesa; jefe de Protocolo de la Presidencia del Gobierno, con rango de director general; presidente ejecutivo del Comité Organizador de la Presidencia Española del Consejo de la Unión Europea, con rango de subsecretario; embajador representante permanente ante la Oficina de las Naciones Unidas y otros organismos internacionales con sede en Ginebra; presidente del Comité Ejecutivo del Alto Comisionado de Naciones Unidas para los Refugiados. Ha sido embajador de España en la República de Austria e introductor de embajadores, MAEC, con rango de embajador..
Katalin Karikó
Katalin Karikó is a professor at University of Szeged and adjunct professor of neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where she has worked for 24 years. She is former senior vice president at BioNTech SE, Mainz, Germany, where she worked between 2013-2022. She received her Ph.D. in biochemistry from University of Szeged, Hungary, in 1982.
For four decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered that nucleoside modifications sup-press immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patents, co-invented with Drew Weissman on nucleoside-modified uridines in mRNA have been used to create the FDA-approved COVID-19 mRNA vaccines by Bi-oNTech/Pfizer and Moderna to fight the pandemic.
For her achievement she received many prestigious awards, including the Japan Prize, the Horwitz Prize, the Franklin Award, the Princess Asturias Award, the BBVA award, Jiménez Díaz Prize, the Breakthrough Prize, the Lasker-DeBakey Clinical Medical Research Award and the 2023 Nobel Prize in Physiology or Medicine.
Adam Smith
Adam Smith is Chief Scientific Officer for Nobel Prize Outreach. His background is in scientific research and science publishing
End of main content